Stock KBLB KRAIG BIOCRAFT LABORATORIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Kraig Biocraft Laboratories, Inc.

Equities

KBLB

US50075W1045

Specialty Chemicals

Delayed OTC Markets
Other stock markets
 03:15:34 2024-04-30 pm EDT 		5-day change 1st Jan Change
0.089 USD -1.24% Intraday chart for Kraig Biocraft Laboratories, Inc. -9.92% +129.97%
Apr. 29 Kraig Biocraft Laboratories, Inc. Reports Signing Agreements in South East Asia CI
Apr. 22 Kraig Biocraft Laboratories, Inc. Successfully Completes Recombinant Cocoon Production from Spring Trials CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 40.03 163.7 107.2 77.85 31.96 39.99
Enterprise Value (EV) 1 40.34 164.9 108.8 77.92 29.77 39.19
P/E ratio -34.2 x -55.7 x -21.4 x -9.16 x -7.86 x -13.2 x
Yield - - - - - -
Capitalization / Revenue 99.7 x - - - - -
EV / Revenue 100 x - - - - -
EV / EBITDA -43.2 x -63.6 x -24.1 x -28.5 x -14.2 x -15.1 x
EV / FCF 242 x -243 x 189 x 20.7 x -48 x -140 x
FCF Yield 0.41% -0.41% 0.53% 4.82% -2.08% -0.72%
Price to Book -4.14 x -15.4 x -9.09 x -7.41 x -3.66 x -3.68 x
Nbr of stocks (in thousands) 816,884 844,468 854,410 927,378 1,030,940 1,033,374
Reference price 2 0.0490 0.1938 0.1255 0.0840 0.0310 0.0387
Announcement Date 3/29/19 3/27/20 3/12/21 3/16/22 3/29/23 4/1/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 0.4016 - - - - -
EBITDA 1 -0.9333 -2.591 -4.506 -2.733 -2.093 -2.587
EBIT 1 -0.9599 -2.622 -4.534 -2.76 -2.121 -2.615
Operating Margin -239.02% - - - - -
Earnings before Tax (EBT) 1 -1.169 -2.91 -4.971 -8.046 -3.842 -3.03
Net income 1 -1.169 -2.91 -4.971 -8.046 -3.842 -3.03
Net margin -291.07% - - - - -
EPS 2 -0.001431 -0.003482 -0.005857 -0.009167 -0.003943 -0.002932
Free Cash Flow 1 0.1665 -0.6774 0.5743 3.758 -0.6201 -0.2809
FCF margin 41.45% - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/29/19 3/27/20 3/12/21 3/16/22 3/29/23 4/1/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 0.31 1.24 1.57 0.07 - -
Net Cash position 1 - - - - 2.19 0.8
Leverage (Debt/EBITDA) -0.3303 x -0.4794 x -0.3475 x -0.0238 x - -
Free Cash Flow 1 0.17 -0.68 0.57 3.76 -0.62 -0.28
ROE (net income / shareholders' equity) 29.8% 59.1% 83.1% 136% 87.1% 65.7%
ROA (Net income/ Total Assets) -646% -399% -279% -80.2% -34.9% -41.9%
Assets 1 0.1811 0.73 1.779 10.03 11 7.234
Book Value Per Share 2 -0.0100 -0.0100 -0.0100 -0.0100 -0.0100 -0.0100
Cash Flow per Share 2 0 0 0 0 0 0
Capex 1 0.01 0.1 - 0.1 0.01 0.01
Capex / Sales 2.85% - - - - -
Announcement Date 3/29/19 3/27/20 3/12/21 3/16/22 3/29/23 4/1/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Specialty Chemicals

1st Jan change Capi.
KRAIG BIOCRAFT LABORATORIES, INC. Stock Kraig Biocraft Laboratories, Inc.
+129.97% 93.58M
ECOLAB INC. Stock Ecolab Inc.
+14.30% 63.38B
SIKA AG Stock Sika AG
-3.80% 46.51B
GIVAUDAN SA Stock Givaudan SA
+13.26% 39.91B
FUJIFILM HOLDINGS CORPORATION Stock Fujifilm Holdings Corporation
+19.57% 25.57B
EMS-CHEMIE HOLDING AG Stock EMS-CHEMIE HOLDING AG
+8.22% 18.95B
CELANESE CORPORATION Stock Celanese Corporation
-0.96% 17.58B
POSCO FUTURE M CO., LTD. Stock Posco Future M Co., Ltd.
-21.03% 16.1B
SYMRISE AG Stock Symrise AG
+1.06% 14.98B
ALBEMARLE CORPORATION Stock Albemarle Corporation
-17.09% 14.78B
Other Specialty Chemicals
  1. Stock Market
  2. Equities
  3. KBLB Stock
  4. Financials Kraig Biocraft Laboratories, Inc.